A young woman treated for suspected methaemoglobinaemia instead experiences worsening haemolysis that reveals a previously ...

If you've been struggling with bloating, gas, or cramping after meals and have gone down the rabbit hole of low-FODMAP diets ...

Although often use interchangeably, yams and sweet potatoes are two distinct foods. Learn about their nutrition and health benefits.

The first infant to undergo gene-editing therapy has accomplished another first — his first steps. KJ Muldoon is walking and ...

Fermenta Biotech Limited (BSE: 506414) (Bloomberg: FERMENTA.IN) (Reuters: FERM.BO), India's leading manufacturer of ...

A new study involving the Medical University of Vienna shows how the multi-resistant fungus Candida auris utilizes carbon ...

Important Safety Information Indication Elfabrio ® (pegunigalsidase alfa for injection) is an enzyme replacement therapy indicated for the longterm treatment of adult patients with a confirmed ...

Elfabrio (R) (pegunigalsidase alfa for injection) is an enzyme replacement therapy indicated for the longterm treatment of adult patients with a confirmed diagnosis of Fabry disease (deficiency of ...

Vegetarians, beware! A vital nutrient, Vitamin B12, often goes unnoticed, despite its crucial role in energy, clear thinking, and nerve health. AIIMS Delhi doctor Dr. Priyanka Sehrawat highlights that ...

As of Wednesday, December 24, Agios Pharmaceuticals, Inc.’s AGIO share price has surged by 16.31%, which has investors questioning if this is right time to sell.

BioMarin Pharmaceutical’s strong rare disease drug portfolio and Amicus acquisition drive a ‘Buy’ rating. Click here to read my latest analysis of BMRN stock.

Amid news of the splashy $4.8 billion Amicus buy, BioMarin has slipped in the discontinuation of a genetic liver disease ...